Humanized Anti-CD25 Antibody(Institute of Hematology & Blood Diseases Hospital)

N/A

Report date: 2024/06/27 20:00:09

Base Information

Drug NameHumanized Anti-CD25 Antibody(Institute of Hematology & Blood Diseases Hospital)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-IL2RA
TargetsInterleukin-2 receptor alpha chain
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A